| __timestamp | Perrigo Company plc | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 675200000 | 6795238 |
| Thursday, January 1, 2015 | 771800000 | 7454247 |
| Friday, January 1, 2016 | 1205500000 | 10345862 |
| Sunday, January 1, 2017 | 1146500000 | 16984203 |
| Monday, January 1, 2018 | 1125800000 | 16187290 |
| Tuesday, January 1, 2019 | 1166100000 | 9299233.54 |
| Wednesday, January 1, 2020 | 1175500000 | 19232000 |
| Friday, January 1, 2021 | 1111400000 | 23611000 |
| Saturday, January 1, 2022 | 1210100000 | 26700000 |
| Sunday, January 1, 2023 | 1274600000 | 28215000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Summit Therapeutics Inc. and Perrigo Company plc from 2014 to 2023. Over this period, Perrigo consistently outspent Summit, with SG&A expenses peaking at approximately $1.27 billion in 2023, marking a 47% increase from 2014. In contrast, Summit's expenses grew by over 300%, reaching nearly $28 million in 2023. This stark difference highlights Perrigo's expansive operational scale compared to Summit's more focused approach. Such insights are invaluable for investors and industry analysts seeking to understand cost structures and strategic priorities within the pharmaceutical sector.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Perrigo Company plc
Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Merus N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Perrigo Company plc Trends and Insights
Perrigo Company plc or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Perrigo Company plc and Mesoblast Limited